FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used to predict the clinical course of chronic heart failure in patients with ischemic heart disease. IL-1β gene rs1143634 polymorphism is determined. If observing the TT genotype, the unfavourable clinical course of the disease is predicted for 5 years.
EFFECT: method provides more accurate prediction of the clinical course of chronic heart failure in patients with ischemic heart disease by determining the polymorphism rs1143634 of the IL-1β gene.
1 cl, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING RISK OF DEVELOPMENT OF ISCHEMIC HEART DISEASE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2620545C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF VARIOUS DEGREES OF SEVERITY OF CHRONIC HEART FAILURE | 2021 |
|
RU2772359C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF CHRONIC CARDIAC FAILURE IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2014 |
|
RU2545899C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF ATRIAL FIBRILLATION IN WOMEN WITH CORONARY HEART DISEASE | 2017 |
|
RU2657942C1 |
| METHOD FOR PREDICTING ADVERSE CARDIOVASCULAR EVENTS WITHIN ONE YEAR AFTER A MYOCARDIAL INFARCTION BASED ON MOLECULAR GENETIC ANALYSIS | 2021 |
|
RU2767269C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF CHRONIC HEART FAILURE | 2017 |
|
RU2697399C2 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING COMPLICATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE ASSOCIATED WITH DIABETES TYPE 2 | 2015 |
|
RU2578449C1 |
| METHOD FOR DETECTING PREDISPOSITION TO THE DEVELOPMENT OF METABOLIC SYNDROME IN THE FORM OF OBESITY IN SCHOOLCHILDREN AGED 7-10 YEARS | 2022 |
|
RU2779085C1 |
| METHOD FOR PREDICTION OF UNFAVORABLE CARDIOVASCULAR EVENTS WITHIN A YEAR AFTER CORONARY ARTERY BYPASS SURGERY | 2020 |
|
RU2731305C1 |
| METHOD OF PREDICTING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2017 |
|
RU2670689C9 |
